Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1456892

registered interest
date	05/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Clinical Trials
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to improve the (1) approval, and (2) set-up processes, for dementia trials.
tabling member printed	Lord Goodlad
uin	HL7690
answer	answer is ministerial correction date of answer 20/04/2022 answer text <p>The Future of UK Clinical Research Delivery: 2021 to 2022 Implementation Plan sets out our commitments to improve study approval and set-up processes. This states that the Medicines and Healthcare products Regulatory Agency and the UK Research Ethics Services plan to implement a combined review of clinical trials to improve study approval. It aims to deliver a streamlined and efficient approval process through a single application route and a coordinated review. We also plan to introduce a National Contract Value Review to accelerate commercial research studies in the National Health Service. While the Implementation Plan is not specific to any disease area, it aims to benefit the research system, including trials for dementia. A copy of the Implementation Plan is attached.</p><p>We are reviewing ways to increase research for dementia and we will set out these ambitions in the forthcoming dementia strategy, which will be published later this year.</p> answering member printed Lord Kamall question first answered 20/04/2022 12:03:21 answering member 4909 label Biography information for Lord Kamall attachment 1 file name the-future-of-uk-clinical-research-delivery-2021-to-2022-implementation-plan.pdf title The Future of UK Clinical Research Delivery: 2021
tabling member	670 label Biography information for Lord Goodlad

1456893

registered interest
date	05/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what key performance indicators will be used to assess the success of the dementia strategy.
tabling member printed	Lord Goodlad
uin	HL7691
answer	answer is ministerial correction date of answer 12/04/2022 answer text <p>We will set out our plans for dementia in England later this year. The strategy will focus on the specific health and care needs of people living with dementia and their carers, including dementia diagnosis, risk reduction and prevention and research. We will work with delivery partners to identify appropriate key performance indicators to monitor progress and assess the success of the strategy.</p> answering member printed Lord Kamall question first answered 12/04/2022 12:19:35 answering member 4909 label Biography information for Lord Kamall
tabling member	670 label Biography information for Lord Goodlad

1456894

registered interest
date	05/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what measures the dementia strategy will include to improve patient access to (1) FDG-PET scans, and (2) CSF tests, for an early and accurate diagnosis of Alzheimer’s disease.
tabling member printed	Lord Goodlad
uin	HL7692
answer	answer is ministerial correction date of answer 20/04/2022 answer text <p>We will set out plans for dementia in England, which will include a focus on dementia diagnosis, later this year.</p><p>The National Institute for Health and Care Excellence’s (NICE) guidelines provide evidence-based recommendations for health and care, including on assessment, management and support for people living with dementia and their carers. NICE’s guideline <em>Dementia: assessment, management and support for people living with dementia and their carers</em> states that clinicians should consider FDG-PET and CSF tests when the diagnosis of Alzheimer’s disease is uncertain. A copy of the guideline is attached.</p><p>Clinical commissioning groups (CCGs) commission the appropriate resources, including such testing, in line with local population health needs. To address dementia waiting lists and increase the number of diagnoses, NHS England and NHS Improvement was allocated £17 million through the Comprehensive Spending Review settlement for mental health in 2021/22. This funding was made available to CCGs in June 2021.</p> answering member printed Lord Kamall question first answered 20/04/2022 12:03:46 answering member 4909 label Biography information for Lord Kamall attachment 1 file name dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109.pdf title Dementia: assessment, management and support
tabling member	670 label Biography information for Lord Goodlad

1456895

registered interest
date	05/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the dementia Moonshot commitment will be delivered as part of the dementia strategy.
tabling member printed	Lord Goodlad
uin	HL7693
answer	answer is ministerial correction date of answer 12/04/2022 answer text <p>We will set out our plans for dementia in England later this year. The strategy will outline ambitions to increase dementia research and the delivery of the moonshot.</p> answering member printed Lord Kamall question first answered 12/04/2022 12:18:59 answering member 4909 label Biography information for Lord Kamall
tabling member	670 label Biography information for Lord Goodlad

1456896

registered interest
date	05/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had regarding the provision of (1) hearing aids, (2) stop smoking services, and (3) treatment for hypertension, to (a) reduce dementia risk, and (b) promote brain health.
tabling member printed	Lord Goodlad
uin	HL7694
answer	answer is ministerial correction date of answer 20/04/2022 answer text <p>There have been no specific discussions. However, the Department is preparing a new dementia strategy, which will include a focus on prevention and risk reduction. As part of this work, in December 2021 the Department had discussions with the British Academy of Audiology on hearing loss as a risk factor for dementia.</p> answering member printed Lord Kamall question first answered 20/04/2022 11:31:08 answering member 4909 label Biography information for Lord Kamall
tabling member	670 label Biography information for Lord Goodlad

1452656

registered interest
date	21/03/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how much the NHS will spend on research into the (1) causes, and (2) treatment, of dementia in each of the next five years.
tabling member printed	Lord Goodlad
uin	HL7138
answer	answer is ministerial correction date of answer 24/03/2022 answer text <p>The Government will invest at least £375 million in neurodegenerative disease research over the next five years to fund projects into a range of diseases, including the causes of and treatments for dementia. The National Institute for Health Research and UK Research and Innovation rely on researchers submitting high-quality applications to access funding. Therefore, details of allocations and timescales are not currently available. All applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p> answering member printed Lord Kamall question first answered 24/03/2022 15:47:17 answering member 4909 label Biography information for Lord Kamall
tabling member	670 label Biography information for Lord Goodlad

1419744

registered interest
date	03/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Strokes: Mechanical Thrombectomy
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what priority is being given by the NHS to the availability of mechanical thrombectomy in the treatment of stroke.
tabling member printed	Lord Goodlad
uin	HL5924
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>Thrombectomy is available in 24 centres in England. There are two non-neuroscience centres currently under development to improve access to thrombectomy.</p><p>The National Health Service is committed increasing the delivery of mechanical thrombectomy to 10% of cases. The latest data shows that 2.1% of patients are receiving a thrombectomy following a stroke. In early 2022, the NHS will undertake a quality review in England to resolve local barriers to increasing the uptake of thrombectomy.</p><p><strong> </strong></p><p> </p> answering member printed Lord Kamall question first answered 07/03/2022 12:09:06 answering member 4909 label Biography information for Lord Kamall
tabling member	670 label Biography information for Lord Goodlad